Advertisement

COVID-19 Federal Responses: Monday, September 20, 2021

COVID-19 Federal Responses: Monday, September 20, 2021
  • A new studyshowssurgical masks are more effective than cloth masks in preventing infections from the Delta variant.
  • A new Centers for Disease Control and Prevention (CDC) studyshowshow the three FDA-authorized COVID-19 vaccines remain effective at preventing hospitalization over time. The study found that Moderna’s vaccine offered the highest protection (93%) followed by Pfizer-BioNTech (88%) and the Johnson & Johnson vaccine (71%).
  • The Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committeevotedunanimously (18-0) to approve a third “booster” dose of the Pfizer COVID-19 vaccine for at risk individuals only, including health care workers and people over 65. The head of NIH, Dr. Anthony Collins,anticipatesFDA将third dose recommendation to more individuals soon as the FDA receives more data.
  • The CDC updated its website and guidelines including explanations of the difference betweenQuarantine and Isolation.

Congress

  • The House Select Subcommittee on the Coronavirus Crisis willmeeton Wednesday, 9/22 at 2:00 pm ET for a hearing regarding pandemic relief programs.

Economy, Vaccines, Testing and Treatment

  • The Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committeevotedunanimously (18-0) to approve a third “booster” dose of the Pfizer COVID-19 vaccine for at risk individuals only, including health care workers and people over 65. The advisory committee voted (16-2) against a recommendation for booster doses for the general population.
    • National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci and National Institutes of Health (NIH) head Dr. Francis Collins expressedsupportfor the advisory panel’s recommendation.
    • However, Dr. Collinsanticipatesthe FDA will extend a third dose recommendation to more individuals once it receives more data.
  • Pfizersays这对ch已完成一个成功的疫苗试验ildren aged 5 to 11. The company is now filing for FDA authorization.
  • A new Centers for Disease Control and Prevention (CDC) studyshowshow the three FDA-authorized COVID-19 vaccines remain effective at preventing hospitalization over time.
    • The study found that Moderna’s vaccine offered the highest protection (93%) followed by Pfizer-BioNTech (88%) and the Johnson & Johnson vaccine (71%).
  • A new studyshowssurgical masks are more effective than cloth masks in preventing infections from the Delta variant.
  • Thisarticledescribes what a “mild” breakthrough case is like.

Advertisement